Biologically meaningful information about heterogeneous cell populations must include insights into their spatial organization within their native tissue niche. However, traditional techniques such as immunohistochemistry or flow cytometry are limited by their inability to provide both spatial context and high-throughput cellular phenotyping simultaneously. ChipCytometry™ Spatial Multiplexing Technology addresses these limitations by combining multiplex immunofluorescence with high-dynamic range spatial imaging to produce superior single-cell resolution of morphologically intact tissue samples.
In this webinar brought to you by Canopy Biosciences, J. Spencer Schwarz will explore how spatial multiplexing revolutionizes scientists’ understanding of spatially heterogenous cell populations in normal and diseased tissues through comprehensive, spatially relevant cellular phenotyping.
Topics to be covered
- Technical challenges of generating biologically relevant spatial biology data
- Considerations for employing high-multiplex assays in clinical studies
- Benefits and considerations for employing multiplexing methods that require a range of abstractions compared to traditional methods
Meet the Speaker:
J. Spencer Schwarz, MS
Product Manager, ChipCytometry™ Instrumentation
Canopy Biosciences® – A Bruker Company